Form 4: Silicon Laboratories Exec Tolany Increases Stake Through Employee Stock Purchase Plan

Sentiment:

SEC Form 4 Filing


Brandon Tolany, Sr VP of Worldwide Sales at Silicon Laboratories, acquired 49 shares of common stock through the company's Employee Stock Purchase Plan on April 30, 2024.

Summary

  • On April 30, 2024, Brandon Tolany, Sr VP of Worldwide Sales at Silicon Laboratories, acquired 49 shares of common stock.
  • The acquisition was made through the Issuer's 2009 Employee Stock Purchase Plan at a price of $77.48 per share.
  • Following the transaction, Tolany directly owns 40,397 shares of Silicon Laboratories Inc.
  • The transaction is exempt under Rule 16b-3(c) and Rule 16b-3(d).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction related to an employee stock purchase plan. There is no indication of significant positive or negative sentiment.

Positives

  • Executive participation in the Employee Stock Purchase Plan can be seen as a positive sign of confidence in the company's future.

Industry Context

This filing is a routine disclosure related to insider transactions and is common for executives participating in employee stock purchase plans. It provides transparency into the ownership positions of company insiders.

Stakeholder Impact

  • The transaction has a minimal impact on stakeholders as it involves a small number of shares acquired through a standard employee program.

Key Dates

DateDescription
04/30/2024Date of transaction: Brandon Tolany acquired 49 shares of common stock through the Employee Stock Purchase Plan.
05/06/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.